About SOMNAIR, INC
Somnair Sleep is developing a non-invasive neurostimulation device for the treatment of obstructive sleep apnea (OSA), currently in the pre-clinical development stage. The company aims to provide a novel, first-in-class solution for OSA patients.
Non-invasive neurostimulation therapy for obstructive sleep apneaProprietary therapy delivery system for airway openingHome-deployed device design
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SOMNAIR, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.